Cargando…

The dominant strain of SARS-CoV-2 is a mosaicism

COVID-19 is seriously threatening human health all over the world. A comprehensive understanding of the genetic mechanisms driving the rapid evolution of its pathogen (SARS-CoV-2) is the key to controlling this pandemic. In this study, by comparing the entire genome sequences of SARS-CoV-2 isolates...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wei, Li, Cheng-Peng, He, Mei, Li, Sheng-Wen, Cao, Lin, Ding, Nai-Zheng, He, Cheng-Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416297/ https://www.ncbi.nlm.nih.gov/pubmed/34487767 http://dx.doi.org/10.1016/j.virusres.2021.198553

Ejemplares similares

Case report: change of dominant strain during dual SARS-CoV-2 infection
por: Samoilov, Andrei E., et al.
Publicado: (2021)

Emerging dominant SARS-CoV-2 variants
por: Chen, Jiahui, et al.
Publicado: (2022)

Discovery of vaccine-like recombinant SARS-CoV-2 circulating in human
por: He, Daniel Chang, et al.
Publicado: (2022)

The Runaway Evolution of SARS-CoV-2 Leading to the Highly Evolved Delta Strain
por: Ruan, Yongsen, et al.
Publicado: (2022)

Analysis of Continuous Mutation and Evolution on Circulating SARS-CoV-2
por: Yu, Jie-Mei, et al.
Publicado: (2020)

The Detection of Periodic Reemergence Events of SARS-CoV-2 Delta Strain in Communities Dominated by Omicron
por: Westcott, Claire E., et al.
Publicado: (2022)

Analysis of genomic distributions of SARS-CoV-2 reveals a dominant strain type with strong allelic associations
por: Yang, Hsin-Chou, et al.
Publicado: (2020)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

Mosaic vaccination schedule: An unexpected card to play against SARS-CoV-2?
por: Ricco, Matteo, et al.
Publicado: (2021)

Alterations in smell or taste in individuals infected with SARS-CoV-2 during periods of Omicron variant dominance
por: Song, Jian, et al.
Publicado: (2023)

Generation and Characterization of a Nanobody Against SARS-CoV
por: Li, Jiang-Fan, et al.
Publicado: (2021)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu, Tong, et al.
Publicado: (2021)

Nonstructural protein 7 and 8 complexes of SARS‐CoV‐2
por: Zhang, Changhui, et al.
Publicado: (2021)

Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
por: Lau, Susanna K.P., et al.
Publicado: (2020)

Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants
por: Kang, Yin-Feng, et al.
Publicado: (2022)

25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor
por: Zu, Shulong, et al.
Publicado: (2020)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID?
por: Carubbi, Francesco, et al.
Publicado: (2021)

Circularized Nanodiscs for Multivalent Mosaic Display of SARS-CoV-2 Spike Protein Antigens
por: Mabrouk, Moustafa T., et al.
Publicado: (2023)

One year of SARS-CoV-2 evolution
por: Wu, Aiping, et al.
Publicado: (2021)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

The m(6)A methylome of SARS-CoV-2 in host cells
por: Liu, Jun’e, et al.
Publicado: (2021)

Molecular evolution and multilocus sequence typing of 145 strains of SARS‐CoV
por: Wang, Zhi-Gang, et al.
Publicado: (2005)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

A serological survey of SARS-CoV-2 in cat in Wuhan
por: Zhang, Qiang, et al.
Publicado: (2020)

Surveillance of SARS-CoV-2 in Zimbabwe shows dominance of variants of concern
por: Mashe, Tapfumanei, et al.
Publicado: (2021)

Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico
por: Taboada, Blanca, et al.
Publicado: (2022)

Comparative effectiveness of the sars-CoV-2 vaccines during delta dominance
por: Islam, Nazmul, et al.
Publicado: (2023)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

SARS-CoV-2 peptides/epitopes for specific and sensitive diagnosis
por: Jiang, He-Wei, et al.
Publicado: (2023)

Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope
por: Dolton, Garry, et al.
Publicado: (2022)

Amino acid variation analysis of surface spike glycoprotein at 614 in SARS-CoV-2 strains
por: Canhui Cao, et al.
Publicado: (2020)

Correlation of SARS-CoV-2 to cancer: Carcinogenic or anticancer? (Review)
por: Li, Ying-Shuang, et al.
Publicado: (2022)

Exposing Structural Variations in SARS-CoV-2 Evolution
por: Yang, Jiaan, et al.
Publicado: (2021)

Exposing structural variations in SARS-CoV-2 evolution
por: Yang, Jiaan, et al.
Publicado: (2021)

Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2
por: Lan, Jun, et al.
Publicado: (2022)

Sequence similarity of SARS-CoV-2 and humans: Implications for SARS-CoV-2 detection
por: Li, Heng, et al.
Publicado: (2022)

SARS-CoV-2 variants of concern dominate in Lahore, Pakistan in April 2021
por: Sarwar, Muhammad Bilal, et al.
Publicado: (2021)

IgA dominates the early neutralizing antibody response to SARS-CoV-2
por: Sterlin, Delphine, et al.
Publicado: (2021)

Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
por: Ridgway, Harry, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ivad8tf22eltc3djgj1ttploj3